SCHEMBL21596699

SCHEMBL21596699

COc1nc(OCC(F)F)c(F)cc1NS(=O)(=O)c1c[nH]c2cc(Cl)ccc12

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC40A1 Q9NP59 1/20 0.38
SGK1 O00141 3/20 0.38
EIF2AK4 Q9P2K8 3/20 0.37
NR4A2 P43354 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CCR2 P41597 2/20 0.36
CYP3A4 P08684 2/20 0.36
EIF2AK3 Q9NZJ5 2/20 0.36
MAP3K20 Q9NYL2 3/20 0.36
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
CCR4 P51679 2/20 0.35
PIK3CA P42336 2/20 0.35
PIK3CD O00329 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35
AXL P30530 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29829927 1.00 SLC40A1 (0.38) SLC40A1SGK1EIF2AK4NR4A2MEN1
SCHEMBL29829916 0.90 MAPT (0.39) SGK1MEN1KMT2A
SCHEMBL23610282 0.90 MAPT (0.39) SGK1MEN1KMT2A
SCHEMBL21596689 0.90 CCR2 (0.36) SLC40A1SGK1CCR2CYP2C9CYP2C19
SCHEMBL29829479 0.90 CCR2 (0.36) SLC40A1SGK1CCR2CYP2C9CYP2C19
SCHEMBL21596705 0.90 NR4A2 (0.43) SLC40A1SGK1EIF2AK4NR4A2MEN1
SCHEMBL29829570 0.90 NR4A2 (0.43) SLC40A1SGK1EIF2AK4NR4A2MEN1
SCHEMBL27053081 0.90 SLC40A1 (0.37) SLC40A1SGK1EIF2AK4MEN1KMT2A
SCHEMBL21596704 0.90 ACLY (0.34) EIF2AK4CYP3A4EIF2AK3MAP3K20CYP2C9
SCHEMBL21596668 0.90 CYP2C9 (0.34) SGK1EIF2AK4CYP3A4EIF2AK3CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112469710-B Pyridyl and pyrazinyl- (aza) indole sulfonamides 优时比制药有限公司 2024-05-14 CN claimed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US claimed
EP-3810591-B1 PYRIDINYL AND PYRAZINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2022-08-10 EP claimed
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides UCB PHARMA GMBH (DE) 2021-07-08 US claimed
CN-112469710-A Pyridyl and pyrazinyl- (aza) indole sulfonamides 优时比制药有限公司 2021-03-09 CN claimed
CN-112469710-B Pyridyl and pyrazinyl- (aza) indole sulfonamides 优时比制药有限公司 2024-05-14 CN disclosed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US disclosed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US disclosed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US disclosed
EP-4074703-B1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2023-11-29 EP disclosed
EP-4074703-A1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB Pharma GmbH (DE) 2022-10-19 EP disclosed
EP-3810591-B1 PYRIDINYL AND PYRAZINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2022-08-10 EP disclosed
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides UCB PHARMA GMBH (DE) 2021-07-08 US disclosed
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides UCB PHARMA GMBH (DE) 2021-07-08 US disclosed
EP-3810591-A1 PYRIDINYL AND PYRAZINYL-(AZA)INDOLSULFONAMIDES UCB Pharma GmbH (DE) 2021-04-28 EP disclosed
CN-112469710-A Pyridyl and pyrazinyl- (aza) indole sulfonamides 优时比制药有限公司 2021-03-09 CN disclosed
WO-2019243303-A1 PYRIDINYL AND PYRAZINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2019-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides GPR17, GPR18, GPR119 SLC40A1 3700/4885SGK1 1683/4885EIF2AK4 1658/4885
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides GPR17, GPR18, GPR119 SLC40A1 3700/4885SGK1 1683/4885EIF2AK4 1658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.